Subscription banner for an ophthalmic newsletter
2023 Eye Drop Recall List: Brand by Brand Breakdown

Since February 2023, the FDA and various companies have been actively initiating recalls of eye drop...

read more
2023 Eye Drop Recall List: Brand by Brand Breakdown
November 22, 2023
FDA Approves Clobetasol Propionate Eye Drop for Post-Op Inflammation and Pain

The U.S. Food and Drug Administration (FDA) has approved clobetasol propionate ophthalmic suspension...

read more
FDA Approves Clobetasol Propionate Eye Drop for Post-Op Inflammation and Pain
March 05, 2024
FDA Approves Formycon and Klinge’s Biosimilar to Eylea®

Formycon AG and its licensing partner Klinge Biopharma GmbH announced the U.S. Food and Drug Adminis...

read more
FDA Approves Formycon and Klinge’s Biosimilar to Eylea®
July 03, 2024
Oculis Announces Positive Phase 2 Results for OCS-05 in Acute Optic Neuritis

Oculis has reported positive topline results from its Phase 2 ACUITY trial evaluating OCS-05, a nove...

read more
Oculis Announces Positive Phase 2 Results for OCS-05 in Acute Optic Neuritis
January 07, 2025
FDA Requests Further Study on Aldeyra Therapeutics’ Reproxalap for DED

Aldeyra Therapeutics announced the receipt of a Complete Response Letter from the U.S. Food and Drug...

read more
FDA Requests Further Study on Aldeyra Therapeutics’ Reproxalap for DED
November 28, 2023
FDA Approves Bausch + Lomb and Novaliq's Miebo for Dry Eye Treatment

Bausch + Lomb announced that the FDA has granted approval for Miebo (perfluorohexyloctane ophthalmic...

read more
FDA Approves Bausch + Lomb and Novaliq's Miebo for Dry Eye Treatment
May 22, 2023
ViGeneron Achieves Key Milestones for VG901 Gene Therapy in Retinitis Pigmentosa

ViGeneron has announced significant progress for its gene therapy candidate VG901, aimed at treating...

read more
ViGeneron Achieves Key Milestones for VG901 Gene Therapy in Retinitis Pigmentosa
January 09, 2025
Heidelberg Engineering Receives FDA Clearance for Enhanced SPECTRALIS® OCTA Module

Heidelberg Engineering announced the FDA clearance of its upgraded SPECTRALIS® OCTA Module featuring...

read more
Heidelberg Engineering Receives FDA Clearance for Enhanced SPECTRALIS® OCTA Module
July 17, 2024
FDA Clears Epithelial Thickness Module for Heidelberg Engineering's Anterion Imaging Platform

Heidelberg Engineering has received FDA clearance for the new Epithelial Thickness Module on its Ant...

read more
FDA Clears Epithelial Thickness Module for Heidelberg Engineering's Anterion Imaging Platform
January 10, 2025
FDA Accepts Revised Supplemental New Drug Application for IZERVAY

The U.S. Food and Drug Administration (FDA) has accepted a revised supplemental New Drug Application...

read more
FDA Accepts Revised Supplemental New Drug Application for IZERVAY
January 13, 2025
More